Diabetes and obesity management tech developer Glooko announced today that it raised $30 million in a Series D financing round.
Palo Alto, Calif.-based Glooko, which develops remote patient monitoring and chronic care management products including data management technologies for insulin delivery devices, said in a news release that proceeds from the financing will be used to accelerate organic growth and strategic initiatives across its product line.
Get the full story at our sister site, Drug Delivery Business News.